Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Open-market buy Director bought 200,000 shares at an average $1.08 ($215,393)
  2. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 22,150 shares at an average $1.10 ($24,390)
  3. 4 Open-market buy Director bought 137,052 shares at an average $1.29 ($176,382)
  4. 4 Exercise or conversion Director acquired 2,288 shares (option exercise)
  5. 4 Open-market buy Director bought 97,290 shares at an average $1.18 ($115,181)
  6. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 26,900 shares at an average $1.18 ($31,866)
  7. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $1.63 ($16,298)
  8. 4 Open-market buy Director bought 5,003 shares at $1.58 ($7,905)
  9. 4 Open-market buy Director bought 50,000 shares at $1.62 ($81,100)
  10. 4 Open-market sale CHIEF MEDICAL OFFICER sold 50,000 shares at $1.56 ($77,870)
  11. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 27,400 shares at $1.82 ($49,871)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 24,100 shares at $2.07 ($49,938)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 22 · 436 filings